Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1977 • 1,526 citations

Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).

1973 • 430 citations

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data

1976 • 340 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

1970 • 317 citations

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.

1984 • 304 citations

High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

1985 • 225 citations

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.

1985 • 190 citations

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

1986 • 155 citations

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

1983 • 146 citations

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).

1983 • 144 citations

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.

1985 • 106 citations

High-dose platinum for the treatment of refractory ovarian cancer

1981 • 84 citations

High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity.

1985 • 79 citations

Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.

1984 • 70 citations

Phase I study of carboplatin given on a five-day intravenous schedule.

1983 • 66 citations

Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat.

1983 • 65 citations

ANTITUMOR ACTIVITY OF CISPLATIN ANALOGS

1980 • 40 citations

Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin.

1986 • 40 citations

Is there cumulative or delayed toxicity from Cis-platinum?

1983 • 37 citations

Experimental Antitumor Activity of Platinum Coordination Complexes

1984 • 23 citations